期刊文献+

阿尔茨海默病的药物治疗进展 被引量:2

下载PDF
导出
出处 《中国全科医学》 CAS CSCD 2001年第6期484-486,共3页 Chinese General Practice
  • 相关文献

参考文献10

  • 1[1]Carcenac D, Martin-Hunyadi C, Kiesrmann M, et al. Extrapyramidal syndrome induced by donepezil. Presse Med, 2000, 29(18): 992-993
  • 2[2]Corey-Bloom J. A randomised trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol, 1998, 1: 55-65
  • 3[3]Rosler M. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. Br Med J, 1999, 318:633-638
  • 4[4]Rogers SL. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurol, 1998,50: 136-145
  • 5[5]Cummings JL. Metrifonat treatment of the cognitive deficits of Alzheimer'sdisease. Neurol, 1998, 50:1214-1221
  • 6[6]Tuszynski MH, Smith DE, Roberts J, et al. Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for3 months does not accelerate beta-amyloid plaque deposition. Exp Neurol, 1998, 154 (2): 573-582
  • 7[7]Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurol, 1998, 50 (4): 996-1002
  • 8[8]Halliday GM, Shepherd CE, McCann H, et al. Effect of antiinflammatory medications on neuropathological findings in Alzheimer's disease. Arch Neurol, 2000, 57 (6): 831-836
  • 9[9]Eikelenboom P, Rozemuller AJ, Hoozemans JJ, et al. Neuroinflamrmation and Alzheimer's disease: clinical and therapeutic implications. Alzheimer's Dis Assoc Disord, 2000, 14 (Suppl1): 54-61
  • 10[10]Gang Yu, Masaki Nishimura, Shigeki Arawaka, et al. Nicastrinmodulates presenilin - mediated notch/glp - 1 signal transductionand βAPP rocessing. Nature, 2000, 407 (6800): 48-54

同被引文献27

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部